Publications by authors named "Jennifer Proctor"

Claim this Profile
O
Overexpression of Neuropeptide Y Leads to Progressive, Cutaneous Inflammatory Fibrotic Responses in Mouse Skin.
Noha Ahmed, Alex D Dawson, Zoya T Anderson, Joseph W Palmer, Misgana I Idris, Jennifer Proctor

J Invest Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease.
Brandon Zimmerman, Leslie A Dakin, Anne Fortier, Evanthia Nanou, Angelo Blasio, Jennifer Proctor

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice.
Asim Saha, Sharon Hyzy, Tahirih Lamothe, Katelyn Hammond, Nicholas Clark, Jennifer Proctor

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of animal-related motor vehicle crashes in select National Park Service units-United States, 1990-2013.
Cara C Cherry, Stephanie Dietz, Erin Sauber-Schatz, Samuel Russell, Jennifer Proctor

Traffic Inj Prev· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of ST Elevation Myocardial Infarction in the Setting of Infective Endocarditis: A Need for Treatment Guidelines.
Nnaemeka Ukwuoma, Daniel Villarreal, Ravi Doobay, Jennifer Proctor

Am J Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies.
Kerrie Faia, Kerry White, Erin Murphy, Jennifer Proctor, Melissa Pink

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.
Olivier De Henau, Matthew Rausch, David Winkler, Luis Felipe Campesato, Cailian Liu, Jennifer Proctor

Nature· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.
Catherine A Evans, Tao Liu, André Lescarbeau, Somarajan J Nair, Louis Grenier, Jennifer L Proctor

ACS Med Chem Lett· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.
Marisa O Peluso, Veronica T Campbell, Joseph A Harari, Thomas T Tibbitts, Jennifer L Proctor

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth.
Veronica T Campbell, Puviindran Nadesan, S Amanda Ali, Chang Ye Yale Wang, Heather Whetstone, Jennifer Proctor

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.
David G Winkler, Kerrie L Faia, Jonathan P DiNitto, Janid A Ali, Kerry F White, Jennifer L Proctor

Chem Biol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor

PLoS One· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation.
Mark D Lessard, Travis L Alley, Jennifer L Proctor, Beth Levy, Nancy Galvin

Clin Immunol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis